Neurocrine Biosciences (NBIX) Current Leases: 2010-2017
Historic Current Leases for Neurocrine Biosciences (NBIX) over the last 7 years, with Dec 2017 value amounting to $62,000.
- Neurocrine Biosciences' Current Leases fell 73.73% to $62,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $62,000, marking a year-over-year decrease of 73.73%. This contributed to the annual value of $62,000 for FY2017, which is 73.73% down from last year.
- Neurocrine Biosciences' Current Leases amounted to $62,000 in Q4 2017, which was down 48.76% from $121,000 recorded in Q3 2017.
- In the past 5 years, Neurocrine Biosciences' Current Leases registered a high of $556,000 during Q2 2015, and its lowest value of $62,000 during Q4 2017.
- In the last 3 years, Neurocrine Biosciences' Current Leases had a median value of $251,000 in 2016 and averaged $295,417.
- Per our database at Business Quant, Neurocrine Biosciences' Current Leases skyrocketed by 84.39% in 2013 and then plummeted by 73.73% in 2017.
- Over the past 5 years, Neurocrine Biosciences' Current Leases (Quarterly) stood at $416,000 in 2013, then grew by 12.26% to $467,000 in 2014, then fell by 8.35% to $428,000 in 2015, then plummeted by 44.86% to $236,000 in 2016, then crashed by 73.73% to $62,000 in 2017.
- Its Current Leases was $62,000 in Q4 2017, compared to $121,000 in Q3 2017 and $181,000 in Q2 2017.